Literature DB >> 9298476

Retrospective review of 50 canine intracranial tumors evaluated by magnetic resonance imaging.

S L Kraft1, P R Gavin, C DeHaan, M Moore, L R Wendling, C W Leathers.   

Abstract

Magnetic resonance imaging (MRI) was performed on 50 dogs with intracranial neoplasia. The following tumor features were assessed: axial origin, location, shape, growth pattern, MRI signal intensity, evidence for edema, and paramagnetic contrast enhancement. Histologic diagnosis included 5 intracranially invading nasal tumors, 7 pituitary tumors, 22 meningiomas, 6 choroid plexus tumors, 7 astrocytomas, 1 ependymoma, and 2 oligodendrogliomas. Axial origin, site, shape, and growth pattern were important diagnostic characteristics for tumor type. Signal intensity and contrast enhancement pattern allowed further differentiation. Characteristic MRI features that facilitate diagnosis and prognosis were identified. Accurate diagnosis of tumor type based on these features was not always possible because of similarities in MRI appearance for some tumors. Tissue biopsy remains necessary for definitive diagnosis of intracranial tumors.

Entities:  

Mesh:

Year:  1997        PMID: 9298476     DOI: 10.1111/j.1939-1676.1997.tb00094.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  16 in total

1.  Allogeneic astrocytoma in immune competent dogs.

Authors:  M E Berens; A Giese; J R Shapiro; S W Coons
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

Review 2.  External beam radiation therapy for canine intracranial meningioma.

Authors:  Hiroto Yoshikawa; Monique N Mayer
Journal:  Can Vet J       Date:  2009-01       Impact factor: 1.008

3.  Canine spontaneous glioma: a translational model system for convection-enhanced delivery.

Authors:  Peter J Dickinson; Richard A LeCouteur; Robert J Higgins; John R Bringas; Richard F Larson; Yoji Yamashita; Michal T Krauze; John Forsayeth; Charles O Noble; Daryl C Drummond; Dmitri B Kirpotin; John W Park; Mitchel S Berger; Krystof S Bankiewicz
Journal:  Neuro Oncol       Date:  2010-05-20       Impact factor: 12.300

4.  Canine intracranial gliomas: relationship between magnetic resonance imaging criteria and tumor type and grade.

Authors:  R T Bentley; C P Ober; K L Anderson; D A Feeney; J F Naughton; J R Ohlfest; M G O'Sullivan; M A Miller; P D Constable; G E Pluhar
Journal:  Vet J       Date:  2013-08-17       Impact factor: 2.688

5.  Correlating magnetic resonance findings with neuropathology and clinical signs in dogs and cats.

Authors:  Charles H Vite; Johnny R Cross
Journal:  Vet Radiol Ultrasound       Date:  2011 Mar-Apr       Impact factor: 1.363

Review 6.  Dogs are man's best friend: in sickness and in health.

Authors:  R Timothy Bentley; Atique U Ahmed; Amy B Yanke; Aaron A Cohen-Gadol; Mahua Dey
Journal:  Neuro Oncol       Date:  2017-03-01       Impact factor: 12.300

7.  Expression of cell adhesion molecules in canine choroid plexus tumors.

Authors:  Naoki Hirose; Kazuyuki Uchida; Satoru Matsunaga; James Kenn Chambers; Hiroyuki Nakayama
Journal:  J Vet Med Sci       Date:  2014-11-06       Impact factor: 1.267

8.  Clinical features, diagnosis, and survival analysis of dogs with glioma.

Authors:  Roberto José-López; Rodrigo Gutierrez-Quintana; Cristian de la Fuente; Edgar G Manzanilla; Anna Suñol; Dolors Pi Castro; Sonia Añor; Daniel Sánchez-Masian; Francisco Fernández-Flores; Emanuele Ricci; Katia Marioni-Henry; Joan Mascort; Lara A Matiasek; Kaspar Matiasek; Paul M Brennan; Martí Pumarola
Journal:  J Vet Intern Med       Date:  2021-06-12       Impact factor: 3.175

Review 9.  Advances in diagnostic and treatment modalities for intracranial tumors.

Authors:  P J Dickinson
Journal:  J Vet Intern Med       Date:  2014-05-09       Impact factor: 3.333

10.  Exclusion of a brain lesion: is intravenous contrast administration required after normal precontrast magnetic resonance imaging?

Authors:  E J Ives; N Rousset; N Heliczer; M E Herrtage; A E Vanhaesebrouck
Journal:  J Vet Intern Med       Date:  2014-01-27       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.